---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-349180"
form_type: "8-K"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2026-08-13T20:10:12+00:00"
generated_at: "2026-08-13T20:12:47.201890+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Arcadia Q2 net loss $6.3M; cash burn only $319K, Zola July sales $740K

## Summary
- Q2 net loss $6.3M ($2.09/share) vs $4.5M loss a year ago; revenue $1.44M, down 1% YoY.
- Cash used in ops only $319K in Q2; cash balance $4.2M after $4M June private placement.
- Zola July sales topped $740K, exceeding $1M through first week of August; Q2 sales flat due to inventory/shipping issues.
- SG&A down $1.0M YoY to all-time low; Q4 2026 launch of 1-liter espresso with pre-launch commitments from two largest customers.
- First half net loss $10.7M ($4.19/share) vs $1.9M loss; includes $5.4M valuation loss on June PIPE and $4.3M unrealized loss on Above Food stock.

## SEC filing metadata
- accession: 0001193125-26-349180
- form_type: 8-K
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2026-08-13T20:10:12+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000119312526349180/0001193125-26-349180-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000119312526349180/rkda-20260813.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-349180
- JSON: https://secwatch.observer/filing/0001193125-26-349180.json
- Plain text: https://secwatch.observer/filing/0001193125-26-349180.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.